DBV Technologies to Participate in Upcoming Investor Conference
June 06 2023 - 4:00PM
DBV Technologies to Participate in Upcoming Investor Conference
Montrouge, France, June 06, 2023
DBV
Technologies to Participate in Upcoming
Investor Conference
DBV Technologies (Euronext: DBV – ISIN:
FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage
biopharmaceutical company, today announced its participation in the
Goldman Sachs 44th Annual Global Healthcare Conference taking place
on June 12th – 15th in Dana Point, CA. Daniel Tassé, Chief
Executive Officer, will engage in a Fireside Chat session on
Wednesday, June 14th at 10:00am PST (1:00pm EST), as well as
one-on-one investor meetings throughout the day.A live webcast of
the presentation will be available on the Investors & Media
section of the Company’s website: DBV Technologies - 1617085
(webcasts.com).
A replay will also be available on DBV
Technologies’ website for 90 days after the
event. About
DBV TechnologiesDBV Technologies is developing Viaskin™,
an investigational proprietary technology platform with broad
potential applications in immunotherapy. Viaskin is based on
epicutaneous immunotherapy, or EPIT™, and is DBV Technologies’
method of delivering biologically active compounds to the immune
system through intact skin. With this new class of non-invasive
product candidates, the Company is dedicated to safely transforming
the care of food allergic patients. DBV Technologies’ food
allergies programs include ongoing clinical trials of Viaskin
Peanut. DBV Technologies has global headquarters in Montrouge,
France, and North American operations in Basking Ridge, NJ. The
Company’s ordinary shares are traded on segment B of Euronext Paris
(Ticker: DBV, ISIN code: FR0010417345) and the Company’s ADSs (each
representing one-half of one ordinary share) are traded on the
Nasdaq Global Select Market (Ticker: DBVT).
Investor Contact Katie
MatthewsDBV
Technologies+1 857-529-2563katie.matthews@dbv-technologies.com
Media ContactAngela MarcucciDBV
Technologies+1 646-842-2393
angela.marcucci@dbv-technologies.com
Viaskin and EPIT are trademarks of DBV
Technologies.
DBV Technologies (EU:DBV)
Historical Stock Chart
From Apr 2024 to May 2024
DBV Technologies (EU:DBV)
Historical Stock Chart
From May 2023 to May 2024